Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Science & Technology Watch.
Press releases published on August 7, 2025

Critical One Signs Definitive Agreement for Uranium Properties
TORONTO, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Critical One Energy Inc. (formerly Madison Metals Inc.) (“Critical One” or the “Company”) (CSE: CRTL) (OTCQB: MMTLF) (FSE: 4EF0) is pleased to announce that the Company’s uranium asset sale to Dark Star Minerals …

Alta Equipment Group Announces Second Quarter 2025 Financial Results
Second Quarter Financial Highlights: Total revenues decreased $6.9 million year over year to $481.2 million but increased $58.2 million sequentially versus the first quarter of 2025 Construction Equipment and Master Distribution revenues increased $10.0 …

ESCO Reports Third Quarter Fiscal 2025 Results
St. Louis, Aug. 07, 2025 (GLOBE NEWSWIRE) -- ESCO Technologies Inc. (NYSE: ESE) (ESCO, or the Company) today reported its operating results for the third quarter ended June 30, 2025 (Q3 2025). On July 21, 2025, the Company announced that it had completed …

Microchip Technology Announces Financial Results for First Quarter of Fiscal Year 2026
For the quarter ended June 30, 2025 Net sales of $1.0755 billion, increased 10.8% sequentially and declined 13.4% from the year ago quarter. The midpoint of our updated guidance provided on May 29, 2025 was net sales of $1.0575 billion. On a GAAP basis: …

Microchip Technology Announces Quarterly Cash Dividend on Common Stock of 45.5 Cents Per Share
CHANDLER, Ariz., Aug. 07, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: MCHP) – Microchip Technology Incorporated, a leading provider of smart, connected, and secure embedded control solutions, today announced that its Board of Directors declared a quarterly cash …

First LLM with Infinite Context Attention is here, wiping out $1.2 billion RAG market value by allowing AI to live outside the Matrix
SAN FRANCISCO, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Silicon Valley startup, iFrame™ AI, has quietly secured a nearly $20 million deal with a leading cloud provider to launch the world’s first Large Attention Model with an infinite context window - a …

Autoscope Technologies Corporation Announces Financial Results and Dividend Declaration
MINNEAPOLIS, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Autoscope Technologies Corporation (OTCQX: AATC) today announced results for its quarter and six months ended June 30, 2025. Net income for the quarter ended June 30, 2025 was $0.14 per basic and diluted share …

Citing Benefits of 232 Tariffs, Century Aluminum Announces Restart to Bring Mt. Holly SC Plant to Full Production, Increasing U.S. Aluminum Production by 10%
CHICAGO, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Century Aluminum Company (NASDAQ:CENX) has announced plans to restart over 50,000MT of idled production at its Mt. Holly, SC smelter. Century will invest approximately $50 million in the effort, create over 100 …

CytomX Therapeutics Announces Second Quarter 2025 Financial Results and Provides Business Update
- May 12, 2025 announcement of positive interim data from ongoing Phase 1 study of CX-2051 (EpCAM Antibody Drug Conjugate) in patients with advanced colorectal cancer (CRC) - - CX-2051 Phase 1 dose expansions on track for data update in Q1 2026. Phase 2 …

Applied Optoelectronics Reports Second Quarter 2025 Results
SUGAR LAND, Texas, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Applied Optoelectronics, Inc. (NASDAQ: AAOI) (“AOI”), a leading provider of advanced optical and HFC networking products that power the internet, today announced financial results for its second quarter …

KLEEN HY-DRO-GEN INC., Announces Launch of World’s first Zero-Emissions Hydrogen Furnace
TORONTO, Aug. 07, 2025 (GLOBE NEWSWIRE) -- KLEEN HY-DRO-GEN INC., ( the “Company”)a Canadian clean energy company, has officially announced the public launch of KLEENHEAT™ hydrogen furnace, the world’s first and only On-Demand, Zero-Emissions home heating …

Pattern Computer Granted Indian Patent for Novel Cancer Therapy Candidate PCI020302
REDMOND, Wash., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Pattern Computer®, Inc. (“Pattern” or “the Company”), the global leader in pattern discovery, today announced that the Indian Patent Office has granted a new patent titled "Therapeutic Compositions and …

Biodesix Announces Second Quarter 2025 Results and Highlights
Q2 2025 Revenue of $20.0 million, an increase of 12% over Q2 2024; Q2 2025 gross profit margin of 80%, a 150-basis point improvement from Q2 2024; Reiterating FY2025 Total Revenue Guidance of $80-85 million; Conference Call and Webcast Today at 4:30 p.m. …

Apyx Medical Corporation Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
CLEARWATER, Fla., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (NASDAQ:APYX) (“Apyx Medical”; the “Company”) today announced that on August 4, 2025, Apyx granted a nonstatuatory stock option to purchase 100,000 shares of common stock to John …

Lifecore Biomedical Reports Fourth Quarter and Fiscal Year 2025 Financial Results and Provides Corporate Update
-- Recorded $128.9 Million in Fiscal 2025 Revenue, Meeting Full-Year Guidance; Maintains Commitment to Mid-Term Outlook -- -- Nine New Programs Signed with New Customers During Fiscal 2025, Reflecting Growth into Modalities Beyond the Company's Traditional …

Relay Therapeutics Reports Second Quarter 2025 Financial Results and Corporate Updates
Presented updated data at ASCO showing consistency with prior data, including 10.3-month median PFS and 39% ORR in patients with PI3Kα-mutated, HR+/HER2- metastatic breast cancer Initiated Phase 3 ReDiscover-2 trial in Q2 Approximately $657 million in cash …

INmune Bio Inc. Announces Second Quarter 2025 Results, Provides Business Update and Announces Management Changes
BOCA RATON, Fla., Aug. 07, 2025 (GLOBE NEWSWIRE) -- INmune Bio Inc. (NASDAQ: INMB) (the “Company”), a clinical-stage immunology company focused on developing treatments that harness the patient’s innate immune system to fight disease, today announces its …

BioAtla Reports Second Quarter 2025 Financial Results and Highlights Recent Progress
CAB-EpCAM x CAB-CD3 bispecific T-cell engager (TCE) (BA3182) Phase 1 dose-escalation study ongoing, currently dosing 1.2 mg cohort; Phase 1 data readout expected 2H 2025 Fast Track Designated Ozuriftamab vedotin (Oz-V; CAB-ROR2-ADC) Phase 2 study ongoing; …

Athira Pharma Reports Second Quarter 2025 Financial Results and Provides Business Update
BOTHELL, Wash., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Athira Pharma, Inc. (NASDAQ: ATHA), a clinical stage biopharmaceutical company focused on developing small molecules to restore neuronal health and slow neurodegeneration, today reported financial results …

Inuvo Posts 25% Growth in the Second Quarter 2025
LITTLE ROCK, Ark., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Inuvo, Inc. (NYSE American: INUV), a leading provider of artificial intelligence AdTech solutions, today announced its financial results for the second quarter and six-month period ended June 30, 2025. …